https://www.selleckchem.com/products/ml-si3.html
r NCT02702037 . Date of trial registration February 26, 2016. It has been proposed that pregnant women and their fetuses may be particularly at risk for poor outcomes due to the coronavirus (COVID-19) pandemic. From the few case series that are available in the literature, women with high risk pregnancies have been associated with higher morbidity. It has been suggested that pregnancy induced immune responses and cardio-vascular changes can exaggerate the course of the COVID-19 infection. A 26-year old Somalian woman (G2P1) presented wit
Like
Comment
Share
